Crossref
Computational Assessment and Molecular Docking of Arylhydrazone Ester Derivatives as SARS-CoV-2 Main Protease Inhibitors
New Materials, Compounds and Applications · 03.04.2026
DOI: 10.62476/nmca.10165 ↗Kurz gefasst
Fachartikel in der Zeitschrift New Materials, Compounds and Applications, online erschienen am 03.04.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Computational Assessment and Molecular Docking of Arylhydrazone Ester Derivatives as SARS-CoV-2 Main Protease Inhibitors. New Materials, Compounds and Applications. https://doi.org/10.62476/nmca.10165
Vancouver
Computational Assessment and Molecular Docking of Arylhydrazone Ester Derivatives as SARS-CoV-2 Main Protease Inhibitors. New Materials, Compounds and Applications. 2026. doi:10.62476/nmca.10165
BibTeX
@article{euvimed2026,
title = {Computational Assessment and Molecular Docking of Arylhydrazone Ester Derivatives as SARS-CoV-2 Main Protease Inhibitors},
journal = {New Materials, Compounds and Applications},
year = {2026},
doi = {10.62476/nmca.10165}
}
EUVIMED